276 related articles for article (PubMed ID: 23617484)
1. Microsimulation model predicts survival benefit of radiofrequency ablation and stereotactic body radiotherapy versus radiotherapy for treating inoperable stage I non-small cell lung cancer.
Tramontano AC; Cipriano LE; Kong CY; Shepard JA; Lanuti M; Gazelle GS; McMahon PM
AJR Am J Roentgenol; 2013 May; 200(5):1020-7. PubMed ID: 23617484
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the Effectiveness of Radiofrequency Ablation With Stereotactic Body Radiation Therapy in Inoperable Stage I Non-Small Cell Lung Cancer: A Systemic Review and Pooled Analysis.
Bi N; Shedden K; Zheng X; Kong FS
Int J Radiat Oncol Biol Phys; 2016 Aug; 95(5):1378-1390. PubMed ID: 27479723
[TBL] [Abstract][Full Text] [Related]
3. Is radiofrequency ablation more effective than stereotactic ablative radiotherapy in patients with early stage medically inoperable non-small cell lung cancer?
Bilal H; Mahmood S; Rajashanker B; Shah R
Interact Cardiovasc Thorac Surg; 2012 Aug; 15(2):258-65. PubMed ID: 22581864
[TBL] [Abstract][Full Text] [Related]
4. Radiofrequency ablation of stage IA non-small cell lung cancer in medically inoperable patients: Results from the American College of Surgeons Oncology Group Z4033 (Alliance) trial.
Dupuy DE; Fernando HC; Hillman S; Ng T; Tan AD; Sharma A; Rilling WS; Hong K; Putnam JB
Cancer; 2015 Oct; 121(19):3491-8. PubMed ID: 26096694
[TBL] [Abstract][Full Text] [Related]
5. Treatment-Related Toxicity in Patients With Early-Stage Non-Small Cell Lung Cancer and Coexisting Interstitial Lung Disease: A Systematic Review.
Chen H; Senan S; Nossent EJ; Boldt RG; Warner A; Palma DA; Louie AV
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):622-631. PubMed ID: 28581404
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer.
Crabtree TD; Denlinger CE; Meyers BF; El Naqa I; Zoole J; Krupnick AS; Kreisel D; Patterson GA; Bradley JD
J Thorac Cardiovasc Surg; 2010 Aug; 140(2):377-86. PubMed ID: 20400121
[TBL] [Abstract][Full Text] [Related]
7. Video-assisted thoracoscopic lobectomy is associated with greater recurrence-free survival than stereotactic body radiotherapy for clinical stage I lung cancer.
Cornwell LD; Echeverria AE; Samuelian J; Mayor J; Casal RF; Bakaeen FG; Omer S; Preventza O; Mai W; Chen G; Simpson KH; Moghanaki D; Zhu AW
J Thorac Cardiovasc Surg; 2018 Jan; 155(1):395-402. PubMed ID: 28888379
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness analysis of stereotactic body radiotherapy and radiofrequency ablation for medically inoperable, early-stage non-small cell lung cancer.
Sher DJ; Wee JO; Punglia RS
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e767-74. PubMed ID: 21300476
[TBL] [Abstract][Full Text] [Related]
9. Radiofrequency ablation of stage IA non-small cell lung cancer in patients ineligible for surgery: results of a prospective multicenter phase II trial.
Palussière J; Chomy F; Savina M; Deschamps F; Gaubert JY; Renault A; Bonnefoy O; Laurent F; Meunier C; Bellera C; Mathoulin-Pelissier S; de Baere T
J Cardiothorac Surg; 2018 Aug; 13(1):91. PubMed ID: 30143031
[TBL] [Abstract][Full Text] [Related]
10. Treatment of stage I lung cancer in high-risk and inoperable patients: comparison of prospective clinical trials using stereotactic body radiotherapy (RTOG 0236), sublobar resection (ACOSOG Z4032), and radiofrequency ablation (ACOSOG Z4033).
Crabtree T; Puri V; Timmerman R; Fernando H; Bradley J; Decker PA; Paulus R; Putnum JB; Dupuy DE; Meyers B
J Thorac Cardiovasc Surg; 2013 Mar; 145(3):692-9. PubMed ID: 23174176
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of Stereotactic Body Radiation Therapy versus Radiofrequency Ablation for Hepatocellular Carcinoma: A Markov Modeling Study.
Pollom EL; Lee K; Durkee BY; Grade M; Mokhtari DA; Wahl DR; Feng M; Kothary N; Koong AC; Owens DK; Goldhaber-Fiebert J; Chang DT
Radiology; 2017 May; 283(2):460-468. PubMed ID: 28045603
[TBL] [Abstract][Full Text] [Related]
12. Wedge resection and radiofrequency ablation for stage I nonsmall cell lung cancer.
Ambrogi MC; Fanucchi O; Dini P; Melfi F; Davini F; Lucchi M; Massimetti G; Mussi A
Eur Respir J; 2015 Apr; 45(4):1089-97. PubMed ID: 25700387
[TBL] [Abstract][Full Text] [Related]
13. Charlson Comorbidity Index predicts patient outcome, in cases of inoperable non-small cell lung cancer treated with radiofrequency ablation.
Simon TG; Beland MD; Machan JT; Dipetrillo T; Dupuy DE
Eur J Radiol; 2012 Dec; 81(12):4167-72. PubMed ID: 22835876
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic Ablative Body Radiotherapy Versus Radical Radiotherapy: Comparing Real-World Outcomes in Stage I Lung Cancer.
Phillips I; Sandhu S; Lüchtenborg M; Harden S
Clin Oncol (R Coll Radiol); 2019 Oct; 31(10):681-687. PubMed ID: 31377081
[TBL] [Abstract][Full Text] [Related]
15. Comparison of survival rate in primary non-small-cell lung cancer among elderly patients treated with radiofrequency ablation, surgery, or chemotherapy.
Lee H; Jin GY; Han YM; Chung GH; Lee YC; Kwon KS; Lynch D
Cardiovasc Intervent Radiol; 2012 Apr; 35(2):343-50. PubMed ID: 21626257
[TBL] [Abstract][Full Text] [Related]
16. Survival Outcomes of Treatment with Radiofrequency Ablation, Stereotactic Body Radiotherapy, or Sublobar Resection for Patients with Clinical Stage I Non-Small-Cell Lung Cancer: A Single-Center Evaluation.
Iguchi T; Hiraki T; Matsui Y; Mitsuhashi T; Katayama N; Katsui K; Soh J; Sakurai J; Gobara H; Toyooka S; Kanazawa S
J Vasc Interv Radiol; 2020 Jul; 31(7):1044-1051. PubMed ID: 32471699
[TBL] [Abstract][Full Text] [Related]
17. Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
Howington JA; Blum MG; Chang AC; Balekian AA; Murthy SC
Chest; 2013 May; 143(5 Suppl):e278S-e313S. PubMed ID: 23649443
[TBL] [Abstract][Full Text] [Related]
18. A national analysis of wedge resection versus stereotactic body radiation therapy for stage IA non-small cell lung cancer.
Yerokun BA; Yang CJ; Gulack BC; Li X; Mulvihill MS; Gu L; Wang X; Harpole DH; D'Amico TA; Berry MF; Hartwig MG
J Thorac Cardiovasc Surg; 2017 Aug; 154(2):675-686.e4. PubMed ID: 28461054
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic body radiation therapy and thermal ablation for treatment of NSCLC: A systematic literature review and meta-analysis.
Laeseke P; Ng C; Ferko N; Naghi A; Wright GWJ; Zhang Y; Laidlaw A; Kalsekar I; Laxmanan B; Ghosh SK; Zhou M; Szapary P; Pritchett M
Lung Cancer; 2023 Aug; 182():107259. PubMed ID: 37321074
[TBL] [Abstract][Full Text] [Related]
20. Early-stage non-small cell lung cancer: surgery, stereotactic radiosurgery, and individualized adjuvant therapy.
Padda SK; Burt BM; Trakul N; Wakelee HA
Semin Oncol; 2014 Feb; 41(1):40-56. PubMed ID: 24565580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
